Close Menu

Cancer, Rethought

Premium

Studying cancer is an enormous undertaking. Many researchers spend their lives trying to understand the genetic origins of the disease in its many forms, and how to stop it in its tracks. While most concentrate their efforts on a specific type of cancer, there are others who have taken on an even more difficult task: studying all cancers at the same time to try to determine which mutations in the cancer genome actually affect human health, and which ones don't. It's a task too large for any one lab, says the Dana-Farber Cancer Institute's Rameen Beroukhim.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.